MustGrow Biologics Corp. (TSXV: MGRO)

Market Cap	95.02M
Revenue (ttm)	4.71M
Net Income (ttm)	-423.95K
Shares Out	51.64M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,930
Open	1.870
Previous Close	1.840
Day's Range	1.710 - 1.880
52-Week Range	0.620 - 2.530
Beta	1.67
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 26, 2024

About MustGrow Biologics

MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard seeds. It provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage and food ...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 2014
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: MGRO

Financial Performance

In 2023, MustGrow Biologics's revenue was 4.71 million, an increase of 72630.36% compared to the previous year's 6,479. Losses were -676,940, -87.84% less than in 2022.